Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BUT-3-YN-1-AMINE, also known as 1-Amino-3-butyne, is a bifunctional linker with versatile applications in various chemical and industrial processes. It is characterized by its unique molecular structure, which allows it to participate in a range of reactions and serve as a key component in the synthesis of different compounds.

14044-63-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 14044-63-4 Structure
  • Basic information

    1. Product Name: BUT-3-YN-1-AMINE
    2. Synonyms: BUT-3-YN-1-AMINE;BUT-3-YNYLAMINE;1-AMino-3-butyne;3-ButynylaMine;4-Amino-1-butyne;1-AMino-3-butyne 95%;3-Butyn-1-amine
    3. CAS NO:14044-63-4
    4. Molecular Formula: C4H7N
    5. Molecular Weight: 69.10508
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 14044-63-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 105℃
    3. Flash Point: 10℃
    4. Appearance: /
    5. Density: 0.844 g/mL at 25 °C
    6. Vapor Pressure: 30.346mmHg at 25°C
    7. Refractive Index: 1.4438 (20℃)
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. PKA: 8.86±0.10(Predicted)
    11. CAS DataBase Reference: BUT-3-YN-1-AMINE(CAS DataBase Reference)
    12. NIST Chemistry Reference: BUT-3-YN-1-AMINE(14044-63-4)
    13. EPA Substance Registry System: BUT-3-YN-1-AMINE(14044-63-4)
  • Safety Data

    1. Hazard Codes: F,C
    2. Statements: 11-22-34
    3. Safety Statements: 26-36/37/39-45
    4. RIDADR: UN 2733 3/PG 2
    5. WGK Germany: 3
    6. RTECS:
    7. HazardClass: N/A
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 14044-63-4(Hazardous Substances Data)

14044-63-4 Usage

Uses

Used in Pharmaceutical Industry:
BUT-3-YN-1-AMINE is used as a bifunctional linker for the Buchwald-Hartwig amination reaction of 1,2,3,4-tetrahydroacridine trifluoromethanesulfonate derivatives. This reaction is crucial in the synthesis of various pharmaceutical compounds, making BUT-3-YN-1-AMINE an essential component in drug development.
Used in Chemical Synthesis:
BUT-3-YN-1-AMINE is used as a reagent to synthesize dialkynylamides from diacids. Its unique structure allows for the formation of these compounds, which have potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals.
Used in Polymer Modification:
BUT-3-YN-1-AMINE is used for the post-polymerization modification of poly(2-alkyl/aryl-2-oxazoline)s (PAOx) polymer by amidation of its methyl ester side chains. This modification enhances the properties of the polymer, making it suitable for a wide range of applications, such as in the production of plastics, coatings, and adhesives.
Used in Material Science:
BUT-3-YN-1-AMINE is used as a crosslinker, which can bind with resin as well as nanocrystalline cellulose. This crosslinking ability facilitates the terminal alkyne group for further functionalizations, making it an important component in the development of advanced materials with improved properties, such as enhanced strength, flexibility, and durability.

Check Digit Verification of cas no

The CAS Registry Mumber 14044-63-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,0,4 and 4 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 14044-63:
(7*1)+(6*4)+(5*0)+(4*4)+(3*4)+(2*6)+(1*3)=74
74 % 10 = 4
So 14044-63-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H7N/c1-2-3-4-5/h1H,3-5H2

14044-63-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (715190)  1-Amino-3-butyne  95%

  • 14044-63-4

  • 715190-500MG

  • 1,079.91CNY

  • Detail

14044-63-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name But-3-yn-1-amine

1.2 Other means of identification

Product number -
Other names 1-amino-3-butyne

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14044-63-4 SDS

14044-63-4Relevant articles and documents

C8-alkynyl- and alkylamino substituted 2′-deoxyguanosines: a universal linker for nucleic acids modification

Saito, Yoshio,Matsumoto, Katsuhiko,Bag, Subhendu Sekhar,Ogasawara, Shinzi,Fujimoto, Kenzo,Hanawa, Kazuo,Saito, Isao

, p. 3578 - 3588 (2008)

Incorporation of modified nucleosides with a flexible universal linker is of great value for post-synthetic modification of nucleic acids. Thus, C8-alkynyl- and alkylamino substituted 2′-deoxyguanosines were synthesized for the first time and incorporated into short oligonucleotide sequences. The preference for syn conformation of these C8-substituted 2′-deoxyguanosines and the stability of the duplexes were discussed. The stabilizing effect of Z-DNA has also been examined.

Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry

Huang, Boxuan,Li, Weijia,Mu, Yu,Shao, Liang,Su, Yangqing,Sun, Mengsi,Xu, Huan,Yang, Fan,Yu, Fei,Zhang, Jihong,Zhang, Yuan

, p. 1759 - 1765 (2021/11/18)

Influenza is a major threat to millions of people worldwide. Entry inhibitors are of particular interest for the development of novel therapeutic strategies for influenza. We have previously discovered oleanolic acid (OA) to be a mild influenza hemagglutinin (HA) inhibitor. In this work, inspired by the 3D structure of HA as a homotrimeric receptor, we designed and synthesized 15 OA trimers with different linkers and central region via the copper-catalyzed azide-alkyne cycloaddition reaction. All of the OA trimers were evaluated for their antiviral activities in vitro, and 12c, 12e, 13c, and 13d were observed to exhibit robust potency (IC50 in the submicromolar range) against influenza A/WSN/33 (H1N1) virus that was stronger than that observed with oseltamivir. In addition, these compounds also displayed strong biological activity against A/Hong Kong/4801/2014 and B/Sichuan/531/2018 (BV). The results of hemagglutination inhibition assays and surface plasmon resonance binding assays suggest that these OA trimers may interrupt the interaction between the HA protein of influenza virus and the host cell sialic acid receptor, thus blocking viral entry. These findings highlight the utility of multivalent OA conjugates to enhance the ligand-target interactions in anti-influenza virus drug design and are also helpful for studying antiviral drugs derived from natural products.

Aldehyde-mediated bioconjugation: Via in situ generated ylides

Parmar, Sangeeta,Pawar, Sharad P.,Iyer, Ramkumar,Kalia, Dimpy

supporting information, p. 14926 - 14929 (2019/12/24)

A technically simple approach for rapid, high-yielding and site-selective bioconjugation has been developed for both in vitro and cellular applications. This method involves the generation of maleimido-phosphonium ylides via 4-nitrophenol catalysis under physiological conditions followed by their Wittig reactions with aldehyde-appended biomolecules.

ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS

-

Paragraph 0244; 0248; 0252; 0256, (2018/10/25)

The present disclosure provides compounds represented by Formula (I): (Formula(I) and pharmaceutically acceptable salts, solvates, e.g., hydrates, and prodrugs thereof, wherein X and n are as defined as set forth in the specification. The present disclosure also provides compounds of Formula (I) for use to treat diseases and conditions, e.g., cancer, wherein inhibition of HDAC provides a benefit.

Chemo- and Site-Selective Alkyl and Aryl Azide Reductions with Heterogeneous Nanoparticle Catalysts

Udumula, Venkatareddy,Nazari, S. Hadi,Burt, Scott R.,Alfindee, Madher N.,Michaelis, David J.

, p. 4423 - 4427 (2016/07/12)

Site-selective modification of bioactive natural products is an effective approach to generating new leads for drug discovery. Herein, we show that heterogeneous nanoparticle catalysts enable site-selective monoreduction of polyazide substrates for the generation of aminoglycoside antibiotic derivatives. The nanoparticle catalysts are highly chemoselective for reduction of alkyl and aryl azides under mild conditions and in the presence of a variety of easily reduced functional groups. High regioselectivity for monoazide reduction is shown to favor reduction of the least sterically hindered azide. We hypothesize that the observed selectivity is derived from the greater ability of less-hindered azide groups to interact with the surface of the nanoparticle catalyst. These results are complementary to previous Staudinger reduction methods that report a preference for selective reduction of electronically activated azides.

Regioselective Amine–Borane Cyclization: Towards the Synthesis of 1,2-BN-3-Cyclohexene by Copper-Assisted Triazole/Gold Catalysis

Motika, Stephen E.,Wang, Qiaoyi,Akhmedov, Novruz G.,Wojtas, Lukasz,Shi, Xiaodong

supporting information, p. 11582 - 11586 (2016/10/24)

The combination of triazole/gold (TA-Au) and Cu(OTf)2is identified as the optimal catalytic system for promoting intramolecular hydroboration for the synthesis of a six-membered cyclic amine–borane. Excellent yields (up to 95 %) and regioselectivities (5-exo vs. 6-endo) were achieved through catalyst control and sequential dilution. Good functional-group tolerance was attained, thus allowing the preparation of highly functionalized cyclic amine–borane substrates, which could not be achieved using other methods. Deuterium-labeling studies support the involvement of a hydride addition to a gold-activated alkyne with subsequent C?B bond formation.

Synthesis of Azabicycles via Cascade Aza-Prins Reactions: Accessing the Indolizidine and Quinolizidine Cores

Chio, Freda K. I.,Guesné, Sébastien J. J.,Hassall, Lorraine,McGuire, Thomas,Dobbs, Adrian P.

, p. 9868 - 9880 (2015/11/03)

The first detailed studies of intramolecular aza-Prins and aza-silyl-Prins reactions, starting from acyclic materials, are reported. The methods allow rapid and flexible access toward an array of [6,5] and [6,6] aza-bicycles, which form the core skeletons of various alkaloids. On the basis of our findings on the aza-Prins and aza-silyl-Prins cyclizations, herein we present simple protocols for the intramolecular preparation of the azabicyclic cores of the indolizidines and quinolizidines using a one-pot cascade process of N-acyliminium ion formation followed by aza-Prins cyclization and either elimination or carbocation trapping. It is possible to introduce a range of different substituents into the heterocycles through a judicial choice of Lewis acid and solvent(s), with halo-, phenyl-, and amido-substituted azabicyclic products all being accessed through these highly diastereoselective processes.

Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: Effect of dimerisation on phosphatase inhibition

Sarkis, Manal,Tran, Diem Ngan,Kolb, Stephanie,Miteva, Maria A.,Villoutreix, Bruno O.,Garbay, Christiane,Braud, Emmanuelle

, p. 7345 - 7350 (2013/02/23)

CDC25 phosphatases are involved in deregulated cell cycle progression and tumor development with poor prognosis. Among the most potent CDC25 inhibitors, quinonoid-based derivatives have been extensively studied. Dimerisation of heterocyclic quinones has led to IRC-083864, a bis-quinone compound with increased CDC25B inhibitory activity. Thirty-one bis-thiazolone derivatives were synthesized and assayed for CDC25 inhibitory activity. Most of the dimers displayed enhanced inhibitory activities with micromolar IC50 values lower than that observed for each thiazolone scaffold separately. Moreover, most of these compounds were selective CDC25 inhibitors. Dimer 40 showed an IC 50 value of 2.9 μM and could inhibit CDC25 activity without generating reactive oxygen species which is likely to occur with quinone-based inhibitors. Molecular docking studies suggested that the dimers could bind simultaneously to the active site and the inhibitor binding pocket.

ANTICANCER DERIVIATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF

-

Page/Page column 14, (2012/04/23)

The invention relates to nicotinamide derivatives which can be used as anticancer drugs.

Synthesis and affinity evaluation of a small library of bidentate cholera toxin ligands: Towards nonhydrolyzable ganglioside mimics

Cheshev, Pavel,Morelli, Laura,Marchesi, Marco,Podlipnik, Crtomir,Bergstroem, Maria,Bernardi, Anna

experimental part, p. 1951 - 1967 (2010/07/05)

A small library of nonhydrolyzable mimics of GM1 ganglioside, featuring galactose and sialic acid as pharmacophoric carbohydrate residues, was synthesized and tested. All compounds were synthesized from readily available precursors using high-performance reactions, including click chemistry protocols, and avoiding O-glycosidic bonds. Some of the most active molecules also feature a point of further derivatization that can be used for conjugation with polyvalent aglycons. Their affinity towards cholera toxin was assessed by weak affinity chromatography, which allowed a systematic evaluation and selection of the best candidates. Affinity could be enhanced up to one or two orders of magnitude over the affinity of the individual pharmacophoric sugar residues.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14044-63-4